- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02413788
Impact of Aerobic Training and Combined in Inflammatory Markers in Patients With Adolescent Idiopathic Scoliosis
Inflammatory markers have been analyzed in several diseases of unknown etiology, in the expectation of increasing therapeutic perspectives. This possibility arises from the different levels of tissue injury with low-grade chronic inflammation that have been observed in studies in which the markers were not evaluated traditionally, and today have influenced clinical management.
The investigators aimed, therefore, to evaluate the inflammatory markers in patients with AIS before and after aerobic and combined exercise training.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Sao Paulo, Brazil, 01221-020
- Santa Casa of Sao Paulo Medical School
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- thoracic curvature ≥ 45 degrees
- indication for surgical treatment of spinal deformity
- absence of pulmonary, cardiac, articular or neurological disorder, atopic dermatitis and previous or current allergy
- agree part in the research with a assent statement and the person responsible with the consent form and informed
Exclusion Criteria:
- acknowledged chronic liver or kidney inflammatory disease
- use of corticosteroids, acetylsalicylic acid or other nonhormonal anti-inflammatory clinical or laboratorial evidence of infection
- severe obesity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: combined group (treadmill and resisted)
- 10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) and resisted training in equipment and free weights for 10 minutes with a set of 10 repetitions in quadriceps, triceps and biceps of the arms and legs (36 sessions)
|
aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate); resisted training in equipment and free weights for 10 minutes with a set of 10 repetitions in quadriceps, triceps and biceps of the arms and legs
|
|
Active Comparator: aerobic group (treadmill)
10 minutes of warming, aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate) for 36 sessions
|
aerobic training 40 minutes on a treadmill (60-80% of maximum heart rate)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
interleukin 1
Time Frame: change from baseline in interleukin 1 at 3 months
|
Inflammatory Markers
|
change from baseline in interleukin 1 at 3 months
|
|
interleukin 6
Time Frame: change from baseline in interleukin 6 at 3 months
|
Inflammatory Markers
|
change from baseline in interleukin 6 at 3 months
|
|
interleukin 8
Time Frame: change from baseline in interleukin 8 at 3 months
|
Inflammatory Markers
|
change from baseline in interleukin 8 at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
distance in six-minute walk test
Time Frame: change from baseline in distance at 3 months
|
analysis of distance
|
change from baseline in distance at 3 months
|
|
oxygen saturation in six-minute walk test
Time Frame: change from baseline in oxygen saturation at 3 months
|
analysis of oxygen saturation at end of test
|
change from baseline in oxygen saturation at 3 months
|
|
systolic blood pressure in six-minute walk test
Time Frame: change from baseline in systolic blood pressure at 3 months
|
analysis of systolic blood pressure at end of test
|
change from baseline in systolic blood pressure at 3 months
|
|
diastolic blood pressure in six-minute walk test
Time Frame: change from baseline in diastolic blood pressure at 3 months
|
analysis of diastolic blood pressure at end of test
|
change from baseline in diastolic blood pressure at 3 months
|
|
heart rate in six-minute walk test
Time Frame: change from baseline in heart rate at 3 months
|
analysis of heart rate at end of test
|
change from baseline in heart rate at 3 months
|
|
respiratory frequency in six-minute walk test
Time Frame: change from baseline in respiratory frequency at 3 months
|
analysis of respiratory frequency at end of test
|
change from baseline in respiratory frequency at 3 months
|
|
Borg scale in six-minute walk test
Time Frame: change from baseline in Borg scale at 3 months
|
analysis of Borg scale at end of test
|
change from baseline in Borg scale at 3 months
|
|
forced vital capacity (FVC)
Time Frame: change from baseline at 3 months
|
analyzed in liters or % of predicted of lung capacity variation from baseline at 3 months
|
change from baseline at 3 months
|
|
maximal inspiratory pressure (MIP)
Time Frame: change from baseline at 3 months
|
analysis of maximal inspiratory pressure variation (cmH2O)
|
change from baseline at 3 months
|
|
maximal expiratory pressure (MEP)
Time Frame: change from baseline at 3 months
|
analysis of maximal expiratory pressure variation (cmH2O)
|
change from baseline at 3 months
|
|
peak expiratory flow
Time Frame: change from baseline at 3 months
|
peak expiratory flow variation analysis in liters / minute (l/min)
|
change from baseline at 3 months
|
|
forced expiratory volume in the first second (FEV1)
Time Frame: change from baseline at 3 months
|
analyzed in liters or % of predicted of lung volume variation from baseline at 3 months
|
change from baseline at 3 months
|
|
forced expiratory volume in the first second (FEV1) / forced vital capacity (FVC)
Time Frame: change from baseline at 3 months
|
Analysis (%) of the relationship between FEV1 and FVC with variation from baseline at 3 months
|
change from baseline at 3 months
|
|
FORCED EXPIRATORY FRACTION (FEF25-75%)
Time Frame: change from baseline at 3 months
|
analyzed in milliliters (ml) of lung volume variation from baseline at 3 months
|
change from baseline at 3 months
|
|
FORCED EXPIRATORY FRACTION (FEF25-75%) / forced vital capacity (FVC)
Time Frame: change from baseline at 3 months
|
Analysis (%) of the relationship between FEV1 and FVC with variation from baseline at 3 months
|
change from baseline at 3 months
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Fcmscsp
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Scoliosis
-
National Scoliosis CenterCompletedAdolescent Idiopathic Scoliosis (AIS) | Neuromuscular Scoliosis | Juvenile Idiopathic Scoliosis | Infantile Idiopathic Scoliosis | Ealy Onset ScoliosisUnited States
-
Manhattan Physical Medicine and Rehabilitation,...RecruitingScoliosis Idiopathic | Scoliosis; Adolescence | Scoliosis; Lumbar RegionUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingScoliosis | Adolescent Idiopathic Scoliosis | Scoliosis; Adolescence | Scoliosis Lumbar RegionTurkey
-
Lahore University of Biological and Applied SciencesGhurki Trust and Teaching HospitalNot yet recruitingScoliosis Idiopathic | Idiopathic Adolescent ScoliosisPakistan
-
Poznan University of Medical SciencesNot yet recruitingScoliosis Idiopathic | Scoliosis; AdolescencePoland
-
Uppsala UniversityUniversity of Oslo; Linkoeping University; Örebro University, Sweden; Skane University... and other collaboratorsNot yet recruitingIdiopathic Adolescent Scoliosis | Idiopathic Juvenile ScoliosisSweden
-
EUROSRecruitingScoliosis Idiopathic | Consent Forms | Scoliosis NeuromuscularFrance
-
Boston Children's HospitalChildren's Hospital Colorado; University of Florida; Cedars-Sinai Medical Center and other collaboratorsRecruitingAdolescent Idiopathic Scoliosis | Idiopathic Scoliosis | Spondylolisthesis | Spine Deformity | Neuromuscular Scoliosis | Congenital ScoliosisUnited States
-
Deep Health Ltd.Not yet recruitingScoliosis | Scoliosis; Adolescence | Scoliosis Lumbar Region | Pathologic Fracture | Scoliosis Kyphosis | Scoliosis Thoracic RegionUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisRecruitingScoliosis | Scoliosis Idiopathic | Scoliosis NeuromuscularFrance
Clinical Trials on combined exercise
-
Hitit UniversityCompleted
-
Xianjie ZhengCompletedObesity | Overweight | Inflammation, Low-Grade | Cardiovascular Diseases, Risk FactorsChina
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension | Healthy
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompletedCoronary Arterial Disease (CAD)Portugal
-
Charles University, Czech RepublicMinistry of Health, Czech Republic; EXCELES LX22NPO5104, CarDiaRecruiting
-
Ege UniversityCompletedMigraine | Chronic MigraineTurkey
-
Evangelismos HospitalCompletedHeart Failure | Diastolic DysfunctionGreece
-
Eastern Mediterranean UniversityUnknownThe Effect of Exercise Training on Balance and Functional Status in Individuals With Osteoarthritis'Osteo Arthritis Knee | BalanceCyprus
-
Yeditepe UniversityThe Scientific and Technological Research Council of TurkeyCompletedMultiple Sclerosis | Multiple Sclerosis (MS) - Relapsing-remittingTurkey (Türkiye)
-
IRCCS San Raffaele RomaCompletedHypertension | Cardiac DiseaseItaly